查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1322222

自动注射器市场 - 2023-2031 年全球行业分析、规模、份额、增长、趋势和预测

Autoinjectors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 189 Pages | 商品交期: 2-10个工作天内

价格

自动注射器市场 - 报告范围

TMR 关于全球自动注射器市场的报告研究了过去以及当前的增长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了该期间全球自动注射器市场的收入2017-2031年，以2023年为基准年，2031年为预测年。该报告还提供了2023年至2031年全球自动注射器市场的复合年增长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领袖和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解自动注射器市场。

该报告深入研究了全球自动注射器市场的竞争格局。全球自动注射器市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概述、财务状况、最新发展和 SWOT 是本报告中介绍的全球自动注射器市场参与者的属性。

目录

第一章：前言

第 2 章：假设和研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 技术进步
  • 疾病发病率和患病率
  • 概述：未来
  • 监管分析
  • COVID-19 影响分析

第 6 章：全球市场分析与预测：按类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按类型，2017-2031
    • 一次性的
    • 可重复使用的
  • 市场吸引力分析：按类型

第 7 章：全球市场分析与预测：按技术分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按技术分类，2017-2031
    • 手持式
    • 穿戴式
  • 市场吸引力分析：按技术分类

第 8 章：全球市场分析与预测：按管理途径

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按给药途径，2017-2031
    • 皮下
    • 肌肉注射
  • 市场吸引力分析：按给药途径

第 9 章：全球市场分析与预测：按指标分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按指标划分，2017-2031
    • 多发性硬化症
    • 类风湿关节炎
    • 糖尿病
    • 过敏反应
    • 其他的
  • 市场吸引力分析：按指标分类

第 10 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 家庭护理设置
    • 医院和诊所
  • 市场吸引力分析：按最终用户

第 11 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 拉美
    • 中东和非洲
  • 市场吸引力分析：按地区

第 12 章：北美市场分析与预测

第 13 章：欧洲市场分析与预测

第 14 章：亚太市场分析与预测

第 15 章：拉丁美洲市场分析与预测

第 16 章：中东和非洲市场分析与预测

第17章：竞争格局

  • 市场参与者 - 竞争矩阵（按公司层级和规模）
  • 公司市场份额分析 (2022)
  • 公司简介
    • Ypsomed Holding AG
    • Novartis AG
    • BD
    • Medmix Healthcare
    • Eli Lilly and Company
    • Sanofi
    • Mylan NV
    • Amgen Inc.
    • SHL Medical AG
    • Recipharm AB
Product Code: TMRGL85651

Autoinjectors Market - Scope of Report

TMR's report on the global Autoinjectors Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Autoinjectors Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Autoinjectors Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Autoinjectors Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Autoinjectors Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Autoinjectors Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Autoinjectors Market.

The report delves into the competitive landscape of the global Autoinjectors Market. Key players operating in the global Autoinjectors Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Autoinjectors Market profiled in this report.

Key Questions Answered in Global Autoinjectors Market Report:

  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Autoinjectors Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Autoinjectors Market - Research Objectives and Research Approach

The comprehensive report on the global Autoinjectors Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Autoinjectors Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Autoinjectors.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Autoinjectors Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Autoinjectors Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancement
  • 5.2. Disease Incidence and Prevalence
  • 5.3. Overview: Future of Autoinjectors
  • 5.4. Regulatory Analysis
  • 5.5. COVID-19 Impact Analysis

6. Global Autoinjectors Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Disposable
    • 6.3.2. Reusable
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Autoinjectors Market Analysis and Forecast, by Technology

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Technology, 2017-2031
    • 7.3.1. Handheld
    • 7.3.2. Wearable
  • 7.4. Market Attractiveness Analysis, by Technology

8. Global Autoinjectors Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 8.3.1. Subcutaneous
    • 8.3.2. Intramuscular
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Autoinjectors Market Analysis and Forecast, by Indication

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Indication, 2017-2031
    • 9.3.1. Multiple Sclerosis
    • 9.3.2. Rheumatoid Arthritis
    • 9.3.3. Diabetes
    • 9.3.4. Anaphylaxsis
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Autoinjectors Market Analysis and Forecast, by End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Homecare Settings
    • 10.3.2. Hospitals & Clinics
  • 10.4. Market Attractiveness Analysis, by End-user

11. Global Autoinjectors Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region

12. North America Autoinjectors Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Disposable
    • 12.2.2. Reusable
  • 12.3. Market Value Forecast, by Technology, 2017-2031
    • 12.3.1. Handheld
    • 12.3.2. Wearable
  • 12.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 12.4.1. Subcutaneous
    • 12.4.2. Intramuscular
  • 12.5. Market Value Forecast, by Indication, 2017-2031
    • 12.5.1. Multiple Sclerosis
    • 12.5.2. Rheumatoid Arthritis
    • 12.5.3. Diabetes
    • 12.5.4. Anaphylaxsis
    • 12.5.5. Others
  • 12.6. Market Value Forecast, by End-user, 2017-2031
    • 12.6.1. Homecare Settings
    • 12.6.2. Hospitals & Clinics
  • 12.7. Market Value Forecast, by Country, 2017-2031
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Type
    • 12.8.2. By Technology
    • 12.8.3. By Route of Administration
    • 12.8.4. By Indication
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Autoinjectors Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Disposable
    • 13.2.2. Reusable
  • 13.3. Market Value Forecast, by Technology, 2017-2031
    • 13.3.1. Handheld
    • 13.3.2. Wearable
  • 13.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 13.4.1. Subcutaneous
    • 13.4.2. Intramuscular
  • 13.5. Market Value Forecast, by Indication, 2017-2031
    • 13.5.1. Multiple Sclerosis
    • 13.5.2. Rheumatoid Arthritis
    • 13.5.3. Diabetes
    • 13.5.4. Anaphylaxsis
    • 13.5.5. Others
  • 13.6. Market Value Forecast, by End-user, 2017-2031
    • 13.6.1. Homecare Settings
    • 13.6.2. Hospitals & Clinics
  • 13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Type
    • 13.8.2. By Technology
    • 13.8.3. By Route of Administration
    • 13.8.4. By Indication
    • 13.8.5. By End-user
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Autoinjectors Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2031
    • 14.2.1. Disposable
    • 14.2.2. Reusable
  • 14.3. Market Value Forecast, by Technology, 2017-2031
    • 14.3.1. Handheld
    • 14.3.2. Wearable
  • 14.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 14.4.1. Subcutaneous
    • 14.4.2. Intramuscular
  • 14.5. Market Value Forecast, by Indication, 2017-2031
    • 14.5.1. Multiple Sclerosis
    • 14.5.2. Rheumatoid Arthritis
    • 14.5.3. Diabetes
    • 14.5.4. Anaphylaxsis
    • 14.5.5. Others
  • 14.6. Market Value Forecast, by End-user, 2017-2031
    • 14.6.1. Homecare Settings
    • 14.6.2. Hospitals & Clinics
  • 14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Type
    • 14.8.2. By Route of Administration
    • 14.8.3. By Technology
    • 14.8.4. By Indication
    • 14.8.5. By End-user
    • 14.8.6. By Country/Sub-region

15. Latin America Autoinjectors Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type, 2017-2031
    • 15.2.1. Disposable
    • 15.2.2. Reusable
  • 15.3. Market Value Forecast, by Technology, 2017-2031
    • 15.3.1. Handheld
    • 15.3.2. Wearable
  • 15.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 15.4.1. Subcutaneous
    • 15.4.2. Intramuscular
  • 15.5. Market Value Forecast, by Indication, 2017-2031
    • 15.5.1. Multiple Sclerosis
    • 15.5.2. Rheumatoid Arthritis
    • 15.5.3. Diabetes
    • 15.5.4. Anaphylaxsis
    • 15.5.5. Others
  • 15.6. Market Value Forecast, by End-user, 2017-2031
    • 15.6.1. Homecare Settings
    • 15.6.2. Hospitals & Clinics
  • 15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Type
    • 15.8.2. By Technology
    • 15.8.3. By Route of Administration
    • 15.8.4. By Indication
    • 15.8.5. By End-user
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Autoinjectors Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Type, 2017-2031
    • 16.2.1. Disposable
    • 16.2.2. Reusable
  • 16.3. Market Value Forecast, by Technology, 2017-2031
    • 16.3.1. Handheld
    • 16.3.2. Wearable
  • 16.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 16.4.1. Subcutaneous
    • 16.4.2. Intramuscular
  • 16.5. Market Value Forecast, by Indication, 2017-2031
    • 16.5.1. Multiple Sclerosis
    • 16.5.2. Rheumatoid Arthritis
    • 16.5.3. Diabetes
    • 16.5.4. Anaphylaxsis
    • 16.5.5. Others
  • 16.6. Market Value Forecast, by End-user, 2017-2031
    • 16.6.1. Homecare Settings
    • 16.6.2. Hospitals & Clinics
  • 16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Type
    • 16.8.2. By Technology
    • 16.8.3. By Route of Administration
    • 16.8.4. By Indication
    • 16.8.5. By End-user
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. Ypsomed Holding AG
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Novartis AG
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.4. Recent Developments
    • 17.3.3. BD
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Medmix Healthcare
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. Eli Lilly and Company
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. Sanofi
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Mylan N.V.
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. Amgen Inc.
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. SHL Medical AG
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Recipharm AB
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments

List of Tables

  • Table 01: Global Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 03: Global Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 04: Global Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 05: Global Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Autoinjectors Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Autoinjectors Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 09: North America Autoinjectors Market (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 10: North America Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 11: North America Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 12: North America Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Europe Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 15: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 16: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 17: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 18: Europe Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 21: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 22: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 23: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 24: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 27: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Technology 2017-2031
  • Table 28: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 29: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 30: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Middle East and Africa Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 33: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 34: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 35: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 36: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Autoinjectors Market Value Share, by Type, 2022
  • Figure 03: Global Autoinjectors Market Value Share, by Technology, 2022
  • Figure 04: Global Autoinjectors Market Value Share, by Indication, 2022
  • Figure 05: Global Autoinjectors Market Value Share, by Route of Administration, 2022
  • Figure 06: Global Autoinjectors Market Value Share, by End-user, 2022
  • Figure 07: Global Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 08: Global Autoinjectors Market Revenue (US$ Mn), by Disposable, 2017-2031
  • Figure 09: Global Autoinjectors Market Revenue (US$ Mn), by Reusable, 2017-2031
  • Figure 10: Global Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 11: Global Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 12: Global Autoinjectors Market Revenue (US$ Mn), by Handheld, 2017-2031
  • Figure 13: Global Autoinjectors Market Revenue (US$ Mn), by Wearable, 2017-2031
  • Figure 14: Global Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 15: Global Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 16: Global Autoinjectors Market Revenue (US$ Mn), by Subcutaneous, 2017-2031
  • Figure 17: Global Autoinjectors Market Revenue (US$ Mn), by Intramuscular, 2017-2031
  • Figure 18: Global Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 19: Global Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 20: Global Autoinjectors Market Revenue (US$ Mn), by Multiple Sclerosis, 2017-2031
  • Figure 21: Global Autoinjectors Market Revenue (US$ Mn), by Rheumatoid Arthritis, 2017-2031
  • Figure 22: Global Autoinjectors Market Revenue (US$ Mn), by Diabetes, 2017-2031
  • Figure 23: Global Autoinjectors Market Revenue (US$ Mn), by Anaphylaxsis, 2017-2031
  • Figure 24: Global Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 25: Global Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 26: Global Autoinjectors Market Value Share Analysis, by Homecare Settings, 2022 and 2031
  • Figure 27: Global Autoinjectors Market Value Share Analysis, by Hospitals & Clinics, 2022 and 2031
  • Figure 28: Global Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 29: North America Autoinjectors Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 30: North America Autoinjectors Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 31: North America Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 32: North America Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 33: North America Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 34: North America Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 35: North America Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 36: North America Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 37: North America Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 38: North America Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 39: North America Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: North America Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 41: Europe Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Europe Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 43: Europe Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 44: Europe Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 45: Europe Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 46: Europe Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 47: Europe Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 48: Europe Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 49: Europe Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 50: Europe Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 51: Europe Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 52: Europe Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 53: Europe Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Asia Pacific Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 55: Asia Pacific Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 56: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Asia Pacific Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 58: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 59: Asia Pacific Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 60: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 61: Asia Pacific Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 62: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 63: Asia Pacific Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 64: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 65: Asia Pacific Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 66: Asia Pacific Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 67: Latin America Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 68: Latin America Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 69: Latin America Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 70: Latin America Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 71: Latin America Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 72: Latin America Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 73: Latin America Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 74: Latin America Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 75: Latin America Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 76: Latin America Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 77: Latin America Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 78: Latin America Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 79: Latin America Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 80: Middle East and Africa Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 81: Middle East and Africa Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 82: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 83: Middle East and Africa Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 84: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 85: Middle East and Africa Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 86: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 87: Middle East and Africa Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 88: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 89: Middle East and Africa Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 90: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 91: Middle East and Africa Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 92: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 93: Company Share Analysis, 2022